Investors / filer profile

Nijhawan Pardeep

Chief Executive Officer

active in 1 company · 1 of 1 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 21
Filings: 1
Companies: 2026-09-01
Last filed

EDGAR · CIK 0001777962 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+271.0%

median move per position

+11.6%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$105.5K bought

All filings on record

Every Form 4 transaction we track for this filer


EDSAEdesa Biotech, Inc.	Grant — · 5,714 sh	2026-09-01	—
EDSAEdesa Biotech, Inc.	Grant — · 3,378 sh	2026-07-02	—
EDSAEdesa Biotech, Inc.	Grant $800.0K · 153,550 sh	2026-06-16	—
EDSAEdesa Biotech, Inc.	Grant — · 96,913 sh	2026-05-27	—
EDSAEdesa Biotech, Inc.	Grant — · 1,159 sh	2026-05-01	—
EDSAEdesa Biotech, Inc.	Buy $2.3K · 1,000 sh	2026-03-02	—
EDSAEdesa Biotech, Inc.	Buy $4.0K · 2,000 sh	2026-03-02	—
EDSAEdesa Biotech, Inc.	Grant — · 10,016 sh	2026-03-02	—
EDSAEdesa Biotech, Inc.	Buy $66.7K · 30,000 sh	2026-02-27	—
EDSAEdesa Biotech, Inc.	Buy $32.5K · 20,571 sh	2026-02-26	—

EDSAGrant

2026-09-01 · Edesa Biotech, Inc.

5,714

—

EDSAGrant

2026-07-02 · Edesa Biotech, Inc.

3,378

—

EDSAGrant

2026-06-16 · Edesa Biotech, Inc.

$800.0K

—

EDSAGrant

2026-05-27 · Edesa Biotech, Inc.

96,913

—

EDSAGrant

2026-05-01 · Edesa Biotech, Inc.

1,159

—

EDSABuy

2026-03-02 · Edesa Biotech, Inc.

$2.3K

—

EDSABuy

2026-03-02 · Edesa Biotech, Inc.

$4.0K

—

EDSAGrant

2026-03-02 · Edesa Biotech, Inc.

10,016

—

EDSABuy

2026-02-27 · Edesa Biotech, Inc.

$66.7K

—

EDSABuy

2026-02-26 · Edesa Biotech, Inc.

$32.5K

—

Newest 10 of 21 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.